Assessment of YME1L and Mitofusin2 As a Possible Diagnostic and Or Therapeutic Target in Hepatocellular Carcinoma. IJBB 2023, 60 (1), 43-54. https://doi.org/10.56042/ijbb.v60i1.62503.